View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 05, 2022
6 min read
Save

Q&A: Failure to include primary care in initial COVID-19 response may have cost lives

Q&A: Failure to include primary care in initial COVID-19 response may have cost lives

The toll of COVID-19 in the U.S. would have been less catastrophic if primary care had been more involved in the initial response efforts, according to a report by researchers at Johns Hopkins Bloomberg School of Public Health.

SPONSORED CONTENT
January 05, 2022
3 min read
Save

CDC tweaks guidance on ending isolation for anyone who ‘wants to test’

CDC tweaks guidance on ending isolation for anyone who ‘wants to test’

The CDC tweaked its guidance for people isolating with COVID-19, adding a recommendation for anyone who “wants to test” but stopping short of telling people that they should test.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
January 05, 2022
3 min read
Save

Q&A: Unpatented COVID-19 vaccine could ‘finally vaccinate the world’

Q&A: Unpatented COVID-19 vaccine could ‘finally vaccinate the world’

An unpatented COVID-19 vaccine recently authorized in India and going into production in other countries could soon vaccinate more people globally than all the doses donated by the U.S. and other G7 countries, two of its developers said.

SPONSORED CONTENT
January 04, 2022
2 min read
Save

COVID-19 vaccination at any time during pregnancy provides benefits

COVID-19 vaccination at any time during pregnancy provides benefits

Women can get vaccinated against COVID-19 at any time during their pregnancy and still see significant benefits for themselves and for their children, according to a study published in Obstetrics & Gynecology.

SPONSORED CONTENT
January 04, 2022
2 min read
Save

CDC backs two FDA moves, waits to hear from ACIP on boosters for kids 12 to 15

CDC backs two FDA moves, waits to hear from ACIP on boosters for kids 12 to 15

The CDC has backed two COVID-19 vaccine authorizations issued by the FDA but will wait to hear from advisors on whether to recommend booster shots for children aged 12 to 15 years.

SPONSORED CONTENT
January 03, 2022
2 min read
Save

FDA authorizes Pfizer boosters for children aged 12 to 15 years, citing omicron

FDA authorizes Pfizer boosters for children aged 12 to 15 years, citing omicron

The FDA on Monday amended an emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to add a booster dose for children aged 12 to 15 years, citing a need to protect them from the omicron variant.

SPONSORED CONTENT
December 30, 2021
2 min read
Save

Non-COVID approvals and guidance you may have missed in 2021

Non-COVID approvals and guidance you may have missed in 2021

Unsurprisingly, many of our most-read stories in 2021 were about the COVID-19 pandemic. Stories about COVID-19 vaccines and therapeutics were popular, especially those dealing with approvals, authorizations or recommendations.

SPONSORED CONTENT
December 28, 2021
2 min read
Save

CDC halves recommended isolation time to 5 days if asymptomatic

CDC halves recommended isolation time to 5 days if asymptomatic

In updated guidance, the CDC said that asymptomatic people with COVID-19 can isolate for 5 days instead of 10, followed by 5 days of wearing a mask around other people.

SPONSORED CONTENT
December 28, 2021
2 min read
Save

New guidance addresses outpatient management of post-prematurity respiratory disease

New guidance addresses outpatient management of post-prematurity respiratory disease

The American Thoracic Society published a new clinical practice guideline to aid physicians in the outpatient management of infants, children and adolescents with post-prematurity respiratory disease.

SPONSORED CONTENT
December 27, 2021
2 min read
Save

Early remdesivir for COVID-19 lowers hospitalization, death risk by 87%

Early remdesivir for COVID-19 lowers hospitalization, death risk by 87%

An early 3-day course of remdesivir lowered the risk for hospitalization or death among nonhospitalized patients at high risk for severe COVID-19 by 87%, according to a study published in The New England Journal of Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails